Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| TRAMADOL/ACET | SANIS HEALTH INC | Anticipated shortage | 37.5MG 325.0MG | New Report | 2020-01-17 | 103483 |
| 5% DEXTROSE INJECTION, USP | BAXTER CORPORATION | Anticipated shortage | 5G | New Report | 2020-01-17 | 103477 |
| PROPOFOL | BAXTER CORPORATION | Anticipated shortage | 10MG | New Report | 2020-01-17 | 103474 |
| REPAGLINIDE | PRO DOC LIMITEE | Actual shortage | 1MG | Updated Report | 2020-01-17 | 102499 |
| ZESTORETIC | ASTRAZENECA CANADA INC | Actual shortage | 25MG 20MG | Updated Report | 2020-01-17 | 101520 |
| TEMODAL | MERCK CANADA INC | Actual shortage | 5MG | Updated Report | 2020-01-17 | 102419 |
| M-M-R II | MERCK CANADA INC | Actual shortage | 5000UNIT 1000UNIT 1000UNIT | Updated Report | 2020-01-17 | 103430 |
| IFEX (IFOSFAMIDE) 3 G/VIAL | BAXTER CORPORATION | Actual shortage | 3G | Updated Report | 2020-01-17 | 103465 |
| ROFACT | BAUSCH HEALTH, CANADA INC. | Actual shortage | 150MG | Updated Report | 2020-01-16 | 93236 |
| ROFACT | BAUSCH HEALTH, CANADA INC. | Anticipated shortage | 300MG | Updated Report | 2020-01-16 | 93246 |
| VINORELBINE INJECTION | FRESENIUS KABI CANADA LTD | Resolved | 10MG | Updated Report | 2020-01-16 | 33098 |
| VINORELBINE INJECTION | FRESENIUS KABI CANADA LTD | Resolved | 10MG | Updated Report | 2020-01-16 | 33103 |
| CEFUROXIME FOR INJECTION, USP | FRESENIUS KABI CANADA LTD | Resolved | 7.5G | Updated Report | 2020-01-16 | 51500 |
| CEFTRIAXONE FOR INJECTION | FRESENIUS KABI CANADA LTD | Resolved | 100G | Updated Report | 2020-01-16 | 57919 |
| CEFAZOLIN FOR INJECTION | FRESENIUS KABI CANADA LTD | Avoided shortage | 10G | Updated Report | 2020-01-16 | 12782 |
| SODIUM CHLORIDE INJECTION, USP | FRESENIUS KABI CANADA LTD | Actual shortage | 234MG | New Report | 2020-01-16 | 103446 |
| SODIUM CHLORIDE INJECTION, USP | FRESENIUS KABI CANADA LTD | Resolved | 234MG | Updated Report | 2020-01-16 | 91027 |
| MIDAZOLAM INJECTION | FRESENIUS KABI CANADA LTD | Resolved | 1MG | Updated Report | 2020-01-16 | 93924 |
| ROPIVACAINE HYDROCHLORIDE INJECTION, USP | FRESENIUS KABI CANADA LTD | Resolved | 2MG | Updated Report | 2020-01-16 | 90057 |
| FLUMAZENIL INJECTION | FRESENIUS KABI CANADA LTD | Resolved | 0.1MG | Updated Report | 2020-01-16 | 95165 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| ZYVOXAM 600 MG | PFIZER CANADA ULC | To be discontinued | 600MG | New Report | 2020-01-17 | 103480 |
| COMBIVENT UDV | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Discontinued | 0.2MG 1.0MG | Updated Report | 2020-01-15 | 84465 |
| RHINOCORT TURBUHALER 100 MCG/DOSE | ASTRAZENECA CANADA INC | To be discontinued | 100MCG | Updated Report | 2020-01-15 | 95737 |
| LIORESAL TAB 10MG | NOVARTIS PHARMACEUTICALS CANADA INC | To be discontinued | 10MG | New Report | 2020-01-10 | 103078 |
| LIORESAL D.S. TAB 20MG | NOVARTIS PHARMACEUTICALS CANADA INC | To be discontinued | 20MG | New Report | 2020-01-10 | 103075 |
